Objective: The aim of this report is to provide insight into real-world healthcare resource use (HCRU) during the critical management of patients surviving acute coronary syndromes (ACS), using data from EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) (NCT01171404). Methods: EPICOR was a prospective, multinational, observational study that enrolled 10 568 ACS survivors from 555 hospitals in 20 countries in Europe and Latin America, between September 2010 and March 2011. HCRU was evaluated in patients with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation ACS (NSTE-ACS), with or without a history of cardiovascular disease (CVD). Multivariable analysis was per...
BACKGROUND: The relationship between in-hospital coronary revascularization rate (CRR) and post-disc...
Relatively limited data are available, particularly from the perspective of a multinational registry...
An abundance of evidence is available from large, randomized clinical trials supporting the efficacy...
Objective: The aim of this report is to provide insight into real-world healthcare resource use (HCR...
OBJECTIVE: The aim of this report is to provide insight into real-world healthcare resource use (HCR...
Background : There is limited information about patterns of use of newer antithrombotic drugs in pat...
AIM: The EPICOR observational study was designed to describe antithrombotic strategies in a broad ac...
Aim: The EPICOR observational study was designed to describe antithrombotic strategies in a broad ac...
AIMS: To describe international patterns and opportunities for improvement of pre- and in-hospital c...
Aims: To describe international patterns and opportunities for improvement of pre- and in-hospital c...
AIMS: Despite advances in the treatment of acute coronary syndromes based on randomized trial data a...
BACKGROUND: In-hospital and postdischarge mortality for acute coronary syndromes (ACS) vary across A...
BACKGROUND: The Global Registry of Acute Coronary Events (GRACE)-a prospective, multinational study ...
Objective: To evaluate the acute phase (pre- and in-hospital) antithrombotic management patterns (AM...
Objectives This sub-analysis of the EPICOR study describes pre-hospital care (PHC) patterns in Belgi...
BACKGROUND: The relationship between in-hospital coronary revascularization rate (CRR) and post-disc...
Relatively limited data are available, particularly from the perspective of a multinational registry...
An abundance of evidence is available from large, randomized clinical trials supporting the efficacy...
Objective: The aim of this report is to provide insight into real-world healthcare resource use (HCR...
OBJECTIVE: The aim of this report is to provide insight into real-world healthcare resource use (HCR...
Background : There is limited information about patterns of use of newer antithrombotic drugs in pat...
AIM: The EPICOR observational study was designed to describe antithrombotic strategies in a broad ac...
Aim: The EPICOR observational study was designed to describe antithrombotic strategies in a broad ac...
AIMS: To describe international patterns and opportunities for improvement of pre- and in-hospital c...
Aims: To describe international patterns and opportunities for improvement of pre- and in-hospital c...
AIMS: Despite advances in the treatment of acute coronary syndromes based on randomized trial data a...
BACKGROUND: In-hospital and postdischarge mortality for acute coronary syndromes (ACS) vary across A...
BACKGROUND: The Global Registry of Acute Coronary Events (GRACE)-a prospective, multinational study ...
Objective: To evaluate the acute phase (pre- and in-hospital) antithrombotic management patterns (AM...
Objectives This sub-analysis of the EPICOR study describes pre-hospital care (PHC) patterns in Belgi...
BACKGROUND: The relationship between in-hospital coronary revascularization rate (CRR) and post-disc...
Relatively limited data are available, particularly from the perspective of a multinational registry...
An abundance of evidence is available from large, randomized clinical trials supporting the efficacy...